Testing T89 to prevent chest pain during stable angina
Part of Heart & circulation, Pain clinical trials.
This Phase 3 trial tests whether T89 reduces angina (chest pain caused by heart-related reduced blood flow) in people with stable angina. You may help confirm the treatment’s benefit by completing symptom tracking and exercise heart tests over several weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18–90 and agree to sign consent and follow study rules.
- Have stable angina: chest pain triggered by physical effort and relieved by rest or nitroglycerin under the study plan.
- Have documented coronary artery disease from history, heart scans/stress testing, or heart imaging showing narrowed arteries.
- Complete medication adjustments before starting: usually stop other angina medicines, and keep only one type of beta blocker or one allowed calcium channel blocker.
- Track angina episodes for the study and have two positive exercise heart tests (Bruce protocol) with similar exercise times.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at managing and treating stable angina, a type of chest discomfort that happens predictably with activity or stress. It may help find better ways to control symptoms and improve daily life, but you must not have certain recent heart events to join.
This study compares two ways of testing the small blood vessels in the heart to understand chest pain when no major blockages are found. It may help doctors learn more about why you have chest pain and how to treat it.
This study tests if specific heart medicines (like beta-blockers or calcium channel blockers) can help people with chest pain that is not caused by blocked arteries. It aims to treat the tiny blood vessels or spasms that may be the real cause of your pain.
This trial tests if beta-blocker medication improves blood flow and reduces resistance in the tiny blood vessels of the heart in people who have chest pain but no major blockages in their arteries.
This trial tests whether a small pressure-reducing device placed in a heart vein (the coronary sinus) can reduce symptoms in people with ongoing chest pain from tiny blood vessel problems. It is for angina that has not improved despite standard heart medicines, and only if special heart tests show reversible reduced blood flow.
This trial tests whether implanting a small device in the heart’s coronary sinus can reduce symptoms in people with long-lasting “refractory” angina despite taking the usual heart medicines. It may help improve how much activity you can do and reduce angina-related limitations.
Hear when a new Chronic Stable Angina Pectoris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.